Respiratory News and Research

RSS

COPD phase III study by Almirall and Forest Laboratories announces positive results

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) delivered by Almirall’s inhaler Genuair® (Pressair™ in the USA).

16 Apr 2013

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

The pathogen that we are talking about is called streptococcus pneumoniae. That is a fairly common bacteria and if you did a nasal swab you would find that quite a lot of people have this bacterium living in their nasal passages.

16 Apr 2013

ACAAI to offer free screenings for allergies and asthma

More than 50 million Americans suffer from allergies and asthma, a number that continues to rise annually. To help children and adults with symptoms of these conditions know if they are at risk, allergists from around the country will conduct the 17th annual Nationwide Asthma Screening Program.

16 Apr 2013

Athletes with vocal cord disorder inappropriately treated for exercise-induced asthma

Athletes with a vocal cord disorder that restricts breathing are more likely to be misdiagnosed and inappropriately treated for exercise-induced asthma, according to research presented today at the Triological Society's 116th Annual Meeting.

15 Apr 2013

Genetic analysis of H7N9 portrays that virus evolves to adapt to human cells

A genetic analysis of the avian flu virus responsible for at least nine human deaths in China portrays a virus evolving to adapt to human cells, raising concern about its potential to spark a new global flu pandemic.

15 Apr 2013

U.S., Chinese researchers developing vaccine for H7N9 avian flu virus; Some question speed of case reporting

"Less than two weeks after Chinese officials released the genetic sequence of a new type of bird flu [H7N9], U.S. vaccine experts are well on the way to making a vaccine to protect people against it," NBC News's "Vitals" blog reports (Fox, 4/10).

12 Apr 2013

New study reveals influence of asbestos exposure, asbestosis and smoking on lung cancer risk

The chances of developing lung cancer associated with asbestos exposure, asbestosis and smoking are dramatically increased when these three risk factors are combined, and quitting smoking significantly reduces the risk of developing lung cancer after long-term asbestos exposure, according to a new study.

12 Apr 2013

Ozone attacks lung surface fluids, causes severe respiratory problems

Research at Birkbeck, University of London uses world-leading neutron sources at ILL and ISIS to demonstrate ozone attacks on lung surface fluids.

12 Apr 2013

Study opens new avenues of research to improve care for patients with COPD

Researchers from Boston University School of Medicine have pinpointed a genetic signature for chronic obstructive pulmonary disease from airway cells harvested utilizing a minimally invasive procedure.

12 Apr 2013

CPAP treatment increases work productivity for people with sleep apnoea

Continuous positive airway pressure is effective at increasing work productivity, according to a new study.

11 Apr 2013

Omeros' GPCR platform unlocks new drug targets against multiple sclerosis

Omeros Corporation today announced positive data in the most commonly used model for studying the clinical and pathological features of multiple sclerosis (MS), further advancing its development program of GPR17-targeting compounds for the treatment of MS. Compounds previously discovered by Omeros that inhibit GPR17, an orphan G protein-coupled receptor (GPCR) unlocked by Omeros, significantly improved function from experimental autoimmune encephalomyelitis (EAE) in mice.

11 Apr 2013

UTHealth study explores ways to reduce infant exposure to secondhand smoke

A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.

11 Apr 2013

Scientists demonstrate feasibility of using already-approved drugs against pathogens

In the most extensive screen of its kind, Texas Biomed scientists in San Antonio have demonstrated the feasibility of repurposing already-approved drugs for use against highly pathogenic bacteria and viruses.

11 Apr 2013

Healthcare professionals suggests new way to evaluate family medicine residents

Medical school graduates entering one family medicine residency program might receive training that is markedly different than another family medicine residency program.

10 Apr 2013

More research needed to measure impact of co-infections on hospital admission

A study at Rhode Island Hospital has found that despite complications, patients co-infected with the pandemic 2009-2010 influenza A H1N1 (pH1N1) and a second respiratory virus were not associated with worse outcomes or admission to the hospital's intensive care unit.

10 Apr 2013

Research findings could help develop effective vaccines against new strains of bird flu

Scientists have described small genetic changes that enable the H5N1 bird flu virus to replicate more easily in the noses of mammals.

9 Apr 2013

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Bristol-Myers Squibb Company announced today that 14 abstracts on the Company's research in liver disease have been accepted for presentation at The International Liver CongressTM 2013, the 48th annual meeting of the European Association for the Study of the Liver, in Amsterdam, April 24 - 28.

8 Apr 2013

AstraZeneca reports fostamatinib Phase 3 study results for treatment of rheumatoid arthritis

AstraZeneca today announced top-line results of OSKIRA-1, a Phase 3 study to assess the efficacy and safety of fostamatinib, the first oral spleen tyrosine kinase inhibitor in development for rheumatoid arthritis.

6 Apr 2013

Walgreens' Take Care Clinics expand access to health care services

Access to health care services is an ongoing challenge to the U.S. health care system. With a physician shortage, aging population, a growing prevalence of chronic diseases and up to 30 million people projected to gain insurance coverage in 2014 through the Affordable Care Act, the issue will become even more critical - and may further impact both patients and the health care system at large.

4 Apr 2013

Researchers identify vulnerability of lung-cancer cells that can be exploited for new therapies

Physician-researchers at UT Southwestern Medical Center have identified a vulnerability of certain lung-cancer cells - a specific genetic weakness that can be exploited for new therapies.

4 Apr 2013

Respiratory News and Research

COPD phase III study by Almirall and Forest Laboratories announces positive results

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

ACAAI to offer free screenings for allergies and asthma

Athletes with vocal cord disorder inappropriately treated for exercise-induced asthma

Genetic analysis of H7N9 portrays that virus evolves to adapt to human cells

U.S., Chinese researchers developing vaccine for H7N9 avian flu virus; Some question speed of case reporting

New study reveals influence of asbestos exposure, asbestosis and smoking on lung cancer risk

Ozone attacks lung surface fluids, causes severe respiratory problems

Study opens new avenues of research to improve care for patients with COPD

CPAP treatment increases work productivity for people with sleep apnoea

Omeros' GPCR platform unlocks new drug targets against multiple sclerosis

UTHealth study explores ways to reduce infant exposure to secondhand smoke

Scientists demonstrate feasibility of using already-approved drugs against pathogens

Healthcare professionals suggests new way to evaluate family medicine residents

More research needed to measure impact of co-infections on hospital admission

Research findings could help develop effective vaccines against new strains of bird flu

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

AstraZeneca reports fostamatinib Phase 3 study results for treatment of rheumatoid arthritis

Walgreens' Take Care Clinics expand access to health care services

Researchers identify vulnerability of lung-cancer cells that can be exploited for new therapies

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News